Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Classification of Skeletal Muscle Fibers01:48

Classification of Skeletal Muscle Fibers

Skeletal muscles continuously produce ATP to provide the energy that enables muscle contractions. Skeletal muscle fibers can be categorized into three types based on differences in their contraction speed and how they produce ATP, as well as physical differences related to these factors. Most human muscles contain all three muscle fiber types, albeit in varying proportions.
Slow-Twitch Muscle Fibers
Slow oxidative, muscle fibers appear red due to large numbers of capillaries and high levels of...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Twinning as a risk factor for neonatal acute intestinal diseases: a case-control study.

Frontiers in pediatrics·2024
Same author

Hospital workers mental health during the COVID-19 pandemic: methods of data collection and characteristics of study sample in a university hospital in Milan (Italy).

BMC medical research methodology·2021
Same author

Correlation of [<sup>18</sup>F] FDG-PET/CT with dosimetry data: recurrence pattern after radiotherapy for head and neck carcinoma.

Radiation oncology (London, England)·2021
Same author

Depression and cardiovascular risk-association among Beck Depression Inventory, PCSK9 levels and insulin resistance.

Cardiovascular diabetology·2020
Same author

Characteristics of 1573 healthcare workers who underwent nasopharyngeal swab testing for SARS-CoV-2 in Milan, Lombardy, Italy.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2020
Same author

Diabetes and work: The need of a close collaboration between diabetologist and occupational physician.

Nutrition, metabolism, and cardiovascular diseases : NMCD·2019

Related Experiment Video

Updated: May 14, 2026

Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

["EOSS" classification in a group of obese workers].

F Mussino1, L Vigna, L Riboldi

  • 1Scuola di Specializzazione in Medicina del Lavoro, Università degli Studi Milano, Italy. fabio.mussino@gmail.com

Giornale Italiano Di Medicina Del Lavoro Ed Ergonomia
|February 12, 2013
PubMed
Summary

The Enhanced Ohio Sleepiness Scale (EOSS) classification better assesses obesity-related work impairments than BMI. This occupational medicine tool aids in evaluating employee health and work eligibility.

More Related Videos

Determining Basal Energy Expenditure and the Capacity of Thermogenic Adipocytes to Expend Energy in Obese Mice
06:57

Determining Basal Energy Expenditure and the Capacity of Thermogenic Adipocytes to Expend Energy in Obese Mice

Published on: November 11, 2021

Body Composition and Metabolic Caging Analysis in High Fat Fed Mice
10:28

Body Composition and Metabolic Caging Analysis in High Fat Fed Mice

Published on: May 24, 2018

Related Experiment Videos

Last Updated: May 14, 2026

Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

Determining Basal Energy Expenditure and the Capacity of Thermogenic Adipocytes to Expend Energy in Obese Mice
06:57

Determining Basal Energy Expenditure and the Capacity of Thermogenic Adipocytes to Expend Energy in Obese Mice

Published on: November 11, 2021

Body Composition and Metabolic Caging Analysis in High Fat Fed Mice
10:28

Body Composition and Metabolic Caging Analysis in High Fat Fed Mice

Published on: May 24, 2018

Area of Science:

  • Occupational Medicine
  • Clinical Classification Systems
  • Public Health

Context:

  • Current obesity classification using Body Mass Index (BMI) has limitations in assessing work-related functional impairments.
  • Obesity's clinical impact and severity are not adequately captured by BMI alone.
  • The Endocrine Society Obesity Society (EOSS) classification considers metabolic complications and functional limitations.

Purpose:

  • To compare the utility of BMI and EOSS classifications for evaluating work-related impairments in obese workers.
  • To assess the effectiveness of EOSS in determining precautionary measures and work eligibility for obese employees.
  • To highlight the potential benefits of adopting the EOSS classification in occupational health settings.

Summary:

  • The study compared Body Mass Index (BMI) and Endocrine Society Obesity Society (EOSS) classifications in obese workers.
  • EOSS proved more effective in identifying clinical impairments and functional limitations impacting work capacity.
  • Results indicate EOSS is a valuable tool for occupational health assessments.

Impact:

  • Suggests a more systematic use of the EOSS classification in occupational medicine for better work-related assessments.
  • Provides evidence for improved evaluation of obese workers' health status and job suitability.
  • Enhances the understanding of how different obesity classifications impact occupational health decisions.